<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04433923</url>
  </required_header>
  <id_info>
    <org_study_id>MansouraU004</org_study_id>
    <nct_id>NCT04433923</nct_id>
  </id_info>
  <brief_title>Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants</brief_title>
  <official_title>Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants: Randomised Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      prospective single center pilot randomized open label clinical trial, conducted at the
      Neonatal care unit of Mansoura University Children's To assess the efficacy and safety of
      aluminum foil use in combination with phototherapy compared with phototherapy alone for
      pathological unconjugated hyperbilirubinaemia in full term newborn We enrolled 234 infants in
      the study who fulfilled the inclusion criteria and were randomly assigned to treatment
      groups, either conventional phototherapy with aluminum foil or conventional phototherapy
      alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 1, 2016</start_date>
  <completion_date type="Actual">December 1, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Total serum bilirubin</measure>
    <time_frame>8 hours of treatment</time_frame>
    <description>measurement of Total serum bilirubin (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total serum bilirubin</measure>
    <time_frame>24 hours of treatment</time_frame>
    <description>measurement of Total serum bilirubin (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total serum bilirubin</measure>
    <time_frame>48 hours of treatment</time_frame>
    <description>measurement of Total serum bilirubin (mg/dl)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of photo therapy</measure>
    <time_frame>average 48 hours</time_frame>
    <description>duration of photo therapy in hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Neonatal Jaundice</condition>
  <arm_group>
    <arm_group_label>GROUP1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phototherapy with aluminum foil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Phototherapy without aluminum foil</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy with aluminum foil</intervention_name>
    <arm_group_label>GROUP1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy without aluminum foil</intervention_name>
    <arm_group_label>GROUP2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Appropriate for gestational age full-term infants with pathological unconjugated
             hyperbilirubinaemia who are candidate for photo therapy according to American academy
             guidelines

        Exclusion Criteria:

          -  Preterm infants, newborn infant with congenital malformations, conjugated
             hyperbilirubinamia, small for gestational age, in need of exchange transfusion, and
             skin abrasions or infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
  </eligibility>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 13, 2020</study_first_submitted>
  <study_first_submitted_qc>June 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>June 13, 2020</last_update_submitted>
  <last_update_submitted_qc>June 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Abd Elazeez Attala Shabaan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaundice, Neonatal</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

